

Airsupra is a rescue inhaler combining Albuterol and Budesonide for asthma. Learn about its uses, dosage, cost, who should take it, and key facts for 2026.
Airsupra is a prescription rescue inhaler that combines Albuterol (a bronchodilator) and Budesonide (an anti-inflammatory corticosteroid) to treat asthma symptoms and reduce exacerbations in adults 18 and older.
Airsupra is the brand name for a combination of Albuterol sulfate (90 mcg) and Budesonide (80 mcg) per actuation, delivered as a metered-dose inhaler (MDI). It is manufactured by AstraZeneca and was FDA-approved in January 2023.
It belongs to the drug class known as antiasthmatic combinations — specifically, a short-acting beta2-adrenergic agonist (SABA) combined with an inhaled corticosteroid (ICS). Airsupra is not a controlled substance.
What makes Airsupra unique is that it's the first rescue inhaler to include an anti-inflammatory corticosteroid alongside the standard bronchodilator. Traditional rescue inhalers like ProAir, Ventolin, and Proventil contain only Albuterol — they open your airways but don't address the underlying inflammation that causes asthma symptoms.
There is currently no generic version of Airsupra available.
Airsupra is FDA-approved for two uses in patients aged 18 and older:
Airsupra is not approved for children under 18 and is not indicated for COPD or other lung conditions.
Airsupra comes as a metered-dose inhaler containing 120 inhalations per canister (10.7g).
Do not use Airsupra if you have a known hypersensitivity (allergy) to Albuterol sulfate, Budesonide, or any of the inactive ingredients in the inhaler.
Use with caution — and discuss with your doctor first — if you have:
If you're pregnant or breastfeeding, talk to your doctor. It's unknown whether Airsupra harms a developing fetus or passes into breast milk. For more details on potential risks, read our side effects guide.
Without insurance, Airsupra costs between $479 and $737 per inhaler, depending on the pharmacy. It's one of the more expensive rescue inhalers on the market because it's brand-only with no generic alternative.
Approximately 80% of commercially insured patients are in plans that cover Airsupra. However, some insurers:
Medicare Part D coverage varies by plan.
For a complete breakdown of savings options, see our guide to saving money on Airsupra.
Airsupra represents a meaningful shift in how rescue inhalers work — combining quick-acting relief with anti-inflammatory protection in a single device. For adults with asthma who want more than just symptom relief from their rescue inhaler, it's worth discussing with your doctor.
The main barriers are cost and availability. There's no generic, the cash price is steep, and not every pharmacy stocks it. But with savings programs and tools like Medfinder to check pharmacy stock, most patients can access it if it's the right fit for their treatment plan.
Want to understand how Airsupra works at a deeper level? Read our mechanism of action explainer.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.